Zhou Y - Search Results

1

Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma.

Song Z, Cheng L, Lu L, Lu W, Zhou Y, Wang Z. Song Z, et al. Among authors: zhou y. Front Endocrinol (Lausanne). 2022 Mar 4;12:764571. doi: 10.3389/fendo.2021.764571. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35308782 Free PMC article. Clinical Trial.

2

Novel nomograms individually predict the survival of patients with soft tissue sarcomas after surgery.

Zhang SL, Wang ZM, Wang WR, Wang X, Zhou YH. Zhang SL, et al. Cancer Manag Res. 2019 Apr 15;11:3215-3225. doi: 10.2147/CMAR.S195123. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114361 Free PMC article.

3

Long Non-Coding RNA LINC01410 Promoted Tumor Progression via the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer.

Lu L, Zhang S, Song Z, Lu W, Wang Z, Zhou Y. Lu L, et al. Among authors: zhou y. Front Oncol. 2021 Jul 12;11:659123. doi: 10.3389/fonc.2021.659123. eCollection 2021. Front Oncol. 2021. PMID: 34322379 Free PMC article.

4

Prognostic implications of SLIT and ROBO1 expression in gallbladder cancer.

Shao Y, Zhou Y, Hou Y, He J, Hu L, Zhang Y, Jiang Y, Lu W, Liu H. Shao Y, et al. Among authors: zhou y. Cell Biochem Biophys. 2014 Nov;70(2):747-58. doi: 10.1007/s12013-014-9976-6. Cell Biochem Biophys. 2014. PMID: 24777813

5

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma.

Wang ZM, Zhang SL, Yang H, Zhuang RY, Guo X, Tong HX, Zhang Y, Lu WQ, Zhou YH. Wang ZM, et al. Among authors: zhou yh. Cancer Med. 2020 May;9(10):3344-3352. doi: 10.1002/cam4.2941. Epub 2020 Mar 17. Cancer Med. 2020. PMID: 32181596 Free PMC article.

6

Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis.

You Y, Guo X, Zhuang R, Zhang C, Wang Z, Shen F, Wang Y, Liu W, Zhang Y, Lu W, Hou Y, Wang J, Zhang X, Lu M, Zhou Y. You Y, et al. Among authors: zhou y. Front Mol Biosci. 2021 Nov 16;8:747650. doi: 10.3389/fmolb.2021.747650. eCollection 2021. Front Mol Biosci. 2021. PMID: 34869583 Free PMC article.

7

Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN.

Guo X, Li S, Tong H, Zhang Y, Ji Y, Zhuang R, Zhang C, You Y, Lu W, Zhou Y. Guo X, et al. Among authors: zhou y. Front Oncol. 2022 Feb 14;12:802074. doi: 10.3389/fonc.2022.802074. eCollection 2022. Front Oncol. 2022. PMID: 35237514 Free PMC article.

8

Case Report: Duodenal Carcinoma in a 40-Year-Old Asian Man With Cowden Syndrome.

Zhao M, Lin X, Fang Y, Zhuang A, Tong H, Lu W, Zhou Y, Zhang Y. Zhao M, et al. Among authors: zhou y. Front Surg. 2022 Jul 12;9:935048. doi: 10.3389/fsurg.2022.935048. eCollection 2022. Front Surg. 2022. PMID: 35903259 Free PMC article.

9

Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts.

Gao Z, Wang L, Song Z, Ren M, Yang Y, Li J, Shen K, Li Y, Ding Y, Yang Y, Zhou Y, Wei C, Gu J. Gao Z, et al. Among authors: zhou y. Front Immunol. 2022 Sep 5;13:954039. doi: 10.3389/fimmu.2022.954039. eCollection 2022. Front Immunol. 2022. PMID: 36131912 Free PMC article.

10

Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.

Li Q, Zhuang R, Zhu J, Lu W, Hou Y, Liu J, Zhang Y, Wang Y, Liu T, Wang Z, Zhou Y. Li Q, et al. Among authors: zhou y. Future Oncol. 2015;11(12):1759-66. doi: 10.2217/fon.15.54. Future Oncol. 2015. PMID: 26075444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,928 results

Search Page

Filters